Search Results - "Wengenack, T.M."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
  2. 2

    Quantitative histological analysis of amyloid deposition in Alzheimer’s double transgenic mouse brain by Wengenack, T.M, Whelan, S, Curran, G.L, Duff, K.E, Poduslo, J.F

    Published in Neuroscience (01-01-2000)
    “…The development of transgenic mice has created new opportunities for the generation of animal models of human neurodegenerative diseases where previously there…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain by Wengenack, T.M., Reyes, D.A., Curran, G.L., Borowski, B.J., Lin, J., Preboske, G.M., Holasek, S.S., Gilles, E.J., Chamberlain, R., Marjanska, M., Jack, C.R., Garwood, M., Poduslo, J.F.

    Published in NeuroImage (Orlando, Fla.) (01-01-2011)
    “…Our laboratory and others have reported the ability to detect individual Alzheimer's disease (AD) amyloid plaques in transgenic mouse brain in vivo by magnetic…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Selective vulnerability and early progression of hippocampal CA1 pyramidal cell degeneration and GFAP-positive astrocyte reactivity in the rat four-vessel occlusion model of transient global ischemia by Ordy, J M, Wengenack, T M, Bialobok, P, Coleman, P D, Rodier, P, Baggs, R B, Dunlap, W P, Kates, B

    Published in Experimental neurology (01-01-1993)
    “…Selective, delayed-onset vulnerability of hippocampal CA1 pyramidal cells has been reported as a unique phenomenon in man and the rat four-vessel occlusion…”
    Get more information
    Journal Article